Adult hospital admissions associated with multiple sclerosis in Finland in 2004–2014
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adult hospital admissions associated with multiple sclerosis in Finland in 2004–2014
Authors
Keywords
-
Journal
ANNALS OF MEDICINE
Volume 50, Issue 4, Pages 354-360
Publisher
Informa UK Limited
Online
2018-04-09
DOI
10.1080/07853890.2018.1461919
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Common comorbidities and survival in MS: Risk for stroke, type 1 diabetes and infections
- (2018) A. Murtonen et al. Multiple Sclerosis and Related Disorders
- Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study
- (2017) Hanne Marie Bøe Lunde et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Epidemiology of Guillain-Barré syndrome in Finland 2004-2014
- (2017) Jussi O.T. Sipilä et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Treatment decisions in multiple sclerosis — insights from real-world observational studies
- (2017) Maria Trojano et al. Nature Reviews Neurology
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of osteoporotic fractures in multiple sclerosis patients in southwest Finland
- (2016) J. Åivo et al. ACTA NEUROLOGICA SCANDINAVICA
- Seasonality of stroke in Finland
- (2016) Jussi O.T. Sipilä et al. ANNALS OF MEDICINE
- Disease-modifying therapies and infectious risks in multiple sclerosis
- (2016) Alexander Winkelmann et al. Nature Reviews Neurology
- Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades
- (2015) N. Grytten et al. ACTA NEUROLOGICA SCANDINAVICA
- High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991–2010)
- (2015) Elaine Kingwell et al. JOURNAL OF NEUROLOGY
- Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2015) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fingolimod: A Review of Its Use in Relapsing-Remitting Multiple Sclerosis
- (2014) Mark Sanford DRUGS
- Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
- (2014) Peter A Calabresi et al. LANCET NEUROLOGY
- Dramatically changing rates and reasons for hospitalization in multiple sclerosis
- (2014) R. A. Marrie et al. NEUROLOGY
- Hospital admission due to infections in multiple sclerosis patients
- (2013) S. Montgomery et al. EUROPEAN JOURNAL OF NEUROLOGY
- Neurological comorbidity and survival in multiple sclerosis
- (2013) Olga Krökki et al. Multiple Sclerosis and Related Disorders
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Quality of the Finnish Hospital Discharge Register: A systematic review
- (2012) Reijo Sund SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
- A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
- (2010) Gavin Giovannoni et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cough Efficacy Is Related to the Disability Status in Patients with Multiple Sclerosis
- (2008) Marina Aiello et al. RESPIRATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started